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Introduction 
Almost 40% of older adults living in western countries are 
obese1,2. An obese older individual has similar life expectancy 
to a non-obese counterpart, but has health care costs 
around $US40,000 higher owing to their increased risk for 
cardiometabolic disorders (e.g. cardiovascular disease and 
type 2 diabetes mellitus; T2DM), and also disability3. Indeed, 
obese older adults have low relative muscle strength4, poor 
mobility5 and increased likelihood of falls6. High levels of calf 
intra- and intermuscular adipose tissue (IMAT) appear to be 
an important contributor to poor physical function in obese 
older adults7. However high IMAT levels are associated with 
T2DM8,9, a condition known to also compromise physical 
function10. It is unclear whether the effects of IMAT on physical 
function in overweight and obese older adults are explained 
by characteristics associated with T2DM, such as increased 
insulin resistance, visceral adiposity and inflammatory 
markers, all of which may independently accelerate functional 
decline11,12.
Peripheral quantitative computed tomography (pQCT) 
scans can be utilised to indirectly assess calf IMAT through 
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assessment of skeletal muscle density (fat between muscle 
fibres and within muscle cells), with lower density indicating 
higher IMAT levels13. We previously reported that higher calf 
muscle density is associated with better muscle strength, 
physical function and balance in non-obese older adults14. 
The aim of the present study was to examine the associations 
of calf muscle density with objectively-assessed and self-
reported physical function in overweight and obese older 
adults, and to determine whether these associations are 
independent of characteristics of T2DM.
Materials and methods
Study design and participants
This is a secondary analysis of a cross-sectional study 
designed to explore associations between components of 
obesity and musculoskeletal health in overweight and obese 
older adults. A convenience sample of eighty-five overweight 
or obese (body mass index [BMI] ≥25 kg/m2) community-
dwelling adults aged ≥50 years residing in Melbourne, 
Australia who responded to advertisements at local hospitals, 
general practices, community groups, and sporting and 
recreation clubs, were recruited for this study. Participants 
were English speaking, capable of walking across a room 
unaided, and had no self-reported diagnosis of progressive 
neurological or psychotic disorders, severe arthritis (awaiting 
a joint replacement), or life expectancy <12 months. The study 
was approved by the Melbourne Health Human Research 
Ethics Committee and participants provided written informed 
consent. All aspects of the research complied with the World 
Medical Association Declaration of Helsinki - Ethical Principles 
for Medical Research Involving Human Subjects.
All testing was conducted at the Clinical Trials Unit at the 
Australian Institute for Musculoskeletal Science (AIMSS) 
between March 2014 and August 2016. A blood sample 
was collected at the hospital pathology centre after an 
overnight fast of at least 10 hours. Serum glucose, high-
density lipoprotein (HDL) cholesterol, and triglycerides 
concentrations were analysed using the automated ADVIA 
1650 Chemistry System (Siemens Healthcare Diagnostics 
Incorporation, Australia). Serum insulin concentration was 
analysed by a commercial solid-phase, enzyme-labelled 
chemiluminescentimmunometric assay (IMMULITE 2000 
Insulin, Siemens, Bayswater, Australia), which has sensitivity 
of 2 µIU/mL. The Homeostatic Model Assessment of 
Insulin Resistance (HOMA-IR) score was calculated from 
fasting glucose and insulin values15. A latex enhanced 
immunoturbidimetric assay determined serum wide range 
C-reactive protein (CRP) concentration (ADVIA 1650; 
CV=3.5%). Pathology reported non-detectable CRP levels as 
<1 mg/L and an arbitrary value of 0.1 mg/L was assigned to 
these cases. The DiaSorin LIAISON (DiaSorin Inc, Stillwater, 
MN, USA) chemiluminescent immunoassay measured serum 
25-hydroxyvitamin D (25OHD) concentrations. 
A self-administered questionnaire including questions on 
employment status and chronic health conditions including 
cardiovascular disease (coronary heart disease and/or 
hypertension) and diabetes was completed. Self-rated health 
was also assessed by response to the question “Would you 
say that in general your health is:” with possible responses of: 
excellent; very good; good; fair; poor. Total minutes of weekly 
moderate and vigorous physical activity was assessed by the 
Active Australia Survey16.
Anthropometrics, body composition and calf muscle density
Weight (Seca 804 electronic scales, Seca, Hamburg, 
Germany) and height (Seca 222 wall-mounted stadiometer, 
Seca, Hamburg, Germany) were measured with footwear, 
headwear, and heavy items of clothing removed. Body mass 
index (BMI) was calculated as weight (kg)/ height (m2).
A whole-body DXA (Hologic Discovery W, Hologic, Bedford 
MA, USA) determined total body fat percentage, appendicular 
lean mass (ALM; kg) and visceral fat area (cm2). DXA-derived 
visceral fat measurements have demonstrated excellent 
agreement with CT assessments17 and predictive ability for 
poor cardiometabolic health18. The study DXA was calibrated 
daily using the manufacturer’s spine phantom and the short-
term intra-individual coefficient of variation (CV) for ALM in 
our laboratory was 1.0%.
A single 2.5-mm transverse pQCT (Stratec XCT3000, 
Stratec Medizintechnik GmbH, Pforzheim, Germany) scan 
with a voxel size of 0.8 mm and scan speed of 20 mm/sec 
was obtained at 66% of tibial length of the dominant leg, 
measured proximally beginning from the tibiotarsal joint 
which was identified by a scout view. The dominant leg 
was preferentially selected for this assessment in order to 
allow comparability of muscle composition measures with 
knee extension strength assessed in the same limb. All 
pQCT scans were acquired and analysed by one observer 
(DS). Calf muscle cross-sectional area (mm2) and density 
(mg/cm3; density of tissue within the muscle compartment 
after removal of subcutaneous fat and bone areas) were 
determined using manufacturer’s algorithms and software 
(version 6.2). The device was calibrated daily using the 
manufacturer’s phantom and short-term intra-individual CV 
for muscle density was 1.0%.
Physical function
As a self-reported assessment of physical function, 
participants completed the self-administered Modified 
Falls Efficacy Scale (M-FES), a 14-item questionnaire with 
demonstrated reliability and validity for assessment of falls 
self-efficacy, where higher scores indicate greater confidence 
in performing activities without falling19. Participants also 
completed the Short Physical Performance Battery (SPPB), 
which is a highly validated measure of physical performance 
and disability in older adults20. A summary score of 0 to 12 
(higher score indicating better function) is obtained based on 
performance in three tasks: gait speed over a 2.44m course, 
repeated chair stands, and standing balance assessments. 
Participants with SPPB scores ≤9 were considered to have 
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poor physical performance21. All participants were capable of 
completing the gait speed test without walking aids.
Mean time taken for two attempts at ascending a 10-
step flight of stairs as quickly as possible (participants could 
use the handrail if required) was also assessed22. Hand grip 
strength of the dominant hand was assessed using a Jamar 
Plus Digital hydraulic hand grip dynamometer (Patterson 
Medical, Bolingbrook, IL, USA). Participants were seated 
with their elbow fully extended in front of them at shoulder 
height and gripped the dynamometer with maximal force 
for three seconds. The test was completed three times with 
a 30-second rest between trials and the mean value was 
recorded. Knee extension strength was assessed using a 
hand-held dynamometer (HHD; Lafayette Manual Muscle 
Tester Model 01165, Lafayette Instrument Company, 
Lafayette, IN, USA). The participant was seated with their 
arms folded across their chest, hip and knee joint angles at 
90 degrees, and feet above the floor. The participant exerted 
maximal force for three seconds to the HHD, which was held 
stationary by the tester about 10 cm above the ankle joint. 
Mean peak force from three trials was calculated. 
Balance path length (total distance travelled by the 
centre of pressure) was assessed during a 30-second 
bipedal standing balance task with feet apart and eyes 
open using a Nintendo Wii Balance Board (RVL-021; 
Nintendo, Kyoto, Japan) and custom software. The test 
measures movements in centre of pressure with acceptable 
reliability and validity compared to a laboratory-grade 
force platform23,24. Mean values from two 30-second trials 
with 30 second inter-trial rest periods were calculated. 
Higher scores indicated poorer balance.
Finally, sarcopenia was defined according to the algorithm 
suggested by the European Working Group on Sarcopenia 
(EWGSOP) as low ALM normalised to height (ALMHt2; men: 
<7.26 kg/m2, women: <5.5 kg/m2) with either low hand grip 
strength (men: <30 kg, women: <20 kg) or low gait speed 
(both men and women ≤0.8 m/s)25.
Statistical analyses
Continuous data were assessed for normality and non-
parametric tests were used as appropriate. In order to 
compare key characteristics of overweight and obesity 
between individuals with and without poor physical 
performance, independent samples t-tests and Mann-
Whitney U tests compared calf muscle density, visceral fat 
area, fasting glucose, HOMA-IR and CRP between groups 
stratified by low (≤9) or normal (>9) SPPB scores. Spearman 
correlations examined associations for muscle density and 
visceral fat area with blood biochemistry parameters, and 
also for fasting glucose, HOMA-IR and CRP levels with physical 
function measures. Scatterplots and Pearson correlations 
were obtained for associations between total body fat, visceral 
fat area, muscle density, and physical function measures. 
Correlation coefficients were interpreted using guidelines 
provided by Hinkle et al.26. Multivariable linear regression 
analyses examined associations of visceral fat area and 
muscle density with fasting glucose after mutual adjustment 
and further adjustment for age, sex, CRP and moderate/
vigorous physical activity. These analyses were repeated 
with HOMA-IR as the dependent variable and a multivariable 
regression also explored associations of visceral fat area and 
muscle density with CRP after mutual adjustment and further 
adjustment for age, sex, fasting glucose and moderate/
vigorous physical activity. Finally, multivariable linear 
regression models examined associations of muscle density 
with physical function measures. To explore associations of 
muscle density after adjustment for demographic variables 
associated with physical function, Model 1 was adjusted for 
age, sex and moderate/vigorous physical activity. Model 2 
was further adjusted for fasting glucose and visceral fat area 
in a stepwise fashion to determine whether associations were 
independent of the T2DM characteristics abdominal obesity 
and hyperglycaemia. Fasting glucose was preferentially 
included in these models over HOMA-IR given it demonstrated 
a stronger association with both physical performance and 
muscle density in univariable analyses. Finally, CRP was added 
as a covariate in Model 3 to determine whether associations 
were additionally independent of systemic inflammation 
levels. Variance Inflation Factors were examined to ensure 
there were no multicollinearity issues in all models. 
Mediation analyses were also performed to examine 
whether fasting glucose, visceral fat area, and CRP mediated 
observed significant associations between muscle density 
and physical function parameters in multivariable linear 
regression models. These analyses were performed using 
the SPSS PROCESS macro which uses bootstrapped 
unstandardised multiple linear regressions with 5,000 
samples27. The estimates of the total indirect effects for the 
mediator variables (fasting glucose, visceral fat area, and 
CRP) were calculated with muscle density as the independent 
variable and the relevant physical function measure as the 
dependent variable. Covariates age, sex and moderate/
vigorous physical activity were also included in these 
mediation models.
P-values <0.05 or 95% confidence intervals (CI) not 
including the null point were considered statistically 
significant. All analyses were performed in SPSS Statistics 
24 (IBM, USA).
Results
Descriptive characteristics for 85 adults aged 50 years 
and older who participated in this study are presented in 
Table 1. Approximately half (52%) were obese (BMI ≥30 kg/
m2), and 19% and 57% had low hand grip strength and low 
gait speed, respectively, but none had low ALMHt2 according 
to the EWGSOP definition of sarcopenia. 
Figure 1 presents scatterplots for associations of total 
body fat and visceral fat area with calf muscle density. Pearson 
correlations revealed similar low negative correlations for 
both visceral fat area and total body fat with muscle density. 
Comparing associations of visceral fat area and muscle 
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density with biochemistry measures (Table 2), visceral fat 
area appeared to be more consistently associated with 
these biochemical outcomes. Muscle density was negatively 
correlated with CRP levels only, whereas visceral fat area was 
positively correlated with fasting glucose, insulin, HOMA-IR, 
triglycerides and CRP, and had a negative correlation with 
HDL cholesterol. Multivariable regression demonstrated 
that visceral fat area was positively associated with fasting 
glucose (0.009; 0.001, 0.017; P=0.027), but not HOMA-IR 
(P=0.070), after adjustment for age, sex, physical activity, 
muscle density and CRP levels. After adjustment for age, 
sex, physical activity and fasting glucose levels, and following 
mutual adjustment, visceral fat area (B=0.025; 95% CI 
0.009, 0.042; P=0.003), but not muscle density (-0.154; 
-0.439, 0.132; P=0.287), was associated with CRP. 
Figure 2 compares characteristics of T2DM according 
to physical performance status. Participants with a SPPB 
score ≤9 (41%; indicating poor physical performance) had 
significantly lower calf muscle density, but similar visceral fat 
area, as those with normal SPPB scores. There were also no 
differences in CRP levels between groups, but fasting glucose 
levels were significantly higher in those with poor physical 
performance. Despite this, there were no differences between 
groups in HOMA-IR scores (P=0.229; data not shown). 
Furthermore, as reported in Table 3, calf muscle density was 
negatively correlated with path length, stair climb and chair 
stands time, and positively correlated with SPPB and M-FES 
scores. Visceral fat area and fasting glucose were negatively 
correlated with SPPB score only. CRP was positively correlated 
with balance path length and stair climb time. 
Table 4 presents multivariable linear regression analyses 
describing associations for calf muscle density with physical 
function measures after adjustment for confounders. In 
Model 1, after adjustment for age, sex and physical activity, 
higher calf muscle density was associated with lower balance 
Table 1. Descriptive characteristics for N=85 participants.
Age (y) 62.8 ± 7.9
Female (%) 58
Retired or pension (%) 42
Self-rated health excellent or very good 
(%)
39
Self-reported CVD (%) 46
Self-reported diabetes (%) 21
Fasting glucose (mmol/L), median (IQR) 5.6 (5.2, 6.5)
Fasting insulin (mIU/L), median (IQR) 7.0 (4.0, 12.3)
HOMA-IR, median (IQR) 1.6 (1.1, 4.0)
HDL cholesterol (mmol/L), median (IQR) 1.4 (1.1, 1.6)
Triglycerides (mmol/L), median (IQR) 1.3 (1.0, 1.8)
CRP (mg/L), median (IQR) 2.0 (0.1, 5.0)
25OHD (nmol/L) 49.6 ± 17.7
Moderate/vigorous activity (mins/week) 130.4 ± 221.2
Body weight (kg) 88.0 ± 18.3
BMI (kg/m2) 32.3 ± 6.1
Total body fat (%) 37.9 ± 8.7
Visceral fat area (g) 194.7 ± 75.5
Calf muscle CSA (mm2) 7499.1 ± 1601.7
Calf muscle density (mg/cm3) 72.0 ± 3.9
Hand grip strength (kg) 31.1 ± 10.9
Knee extension strength (kg) 17.1 ± 9.3 
Path length (cm) 40.4 ± 17.4
Stair climb time (s) 5.9 ± 2.6
Chair stands time (s) 14.5 ± 8.9
Gait speed (m/s) 0.8 ± 0.2
SPPB score 9.9 ± 1.8
M-FES score 127.6 ± 18.3
All data are mean ± SD or frequency (%) unless otherwise 
specified. Abbreviations: CVD; cardiovascular disease, IQR; 
interquartile range, HOMA-IR; Homeostatic Model Assessment of 
Insulin Resistance, HDL; high-density lipoprotein, CRP; C-reactive 
protein, 25OHD; 25-hydroxyvitamin D, BMI; body mass index, 
ALM; appendicular lean mass, CSA; cross-sectional area, SPPB; 
Short Physical Performance Battery, M-FES; Modified Falls 
Efficacy Scale. 
Figure 1. Scatterplots for associations of calf muscle density 
with total body fat percentage and visceral fat area.
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path length, stair climb and chair stands time, and higher 
overall SPPB and M-FES scores. Each of these associations 
remained significant after further adjustment for fasting 
glucose and visceral fat area (Model 2), and additionally, CRP 
(Model 3). Bootstrapped mediation models adjusted for age, 
sex and physical activity demonstrated that fasting glucose, 
visceral fat area and CRP did not mediate the significant 
associations between muscle density and physical function 
measures observed in model 3. The estimates of the total 
indirect effects of these variables on path length (95% CI: 
-0.90, 0.33), stair climb time (-0.15, 0.02), chair stands time 
(-0.15, 0.53), SPPB score (-0.04, 0.09) and M-FES score 
(-0.52, 0.46) were all non-significant. 
Discussion
This cross-sectional study of community-dwelling 
overweight and obese older adults demonstrated that 
although some features of T2DM are associated with poorer 
physical performance, they do not mediate associations of 
lower levels of calf muscle density with reduced physical 
function. This suggests that effects of lower muscle density 
unrelated to T2DM are responsible for poorer function during 
ageing, and is supported by the fact that muscle density 
itself was not independently associated with cardiometabolic 
markers. Muscle density is only one component of many 
neuromuscular factors which undergo deleterious changes 
Table 2. Correlation coefficients (P-values) for calf muscle density and visceral fat area with biochemistry parameters.
Calf muscle density Visceral fat area
Fasting glucose -0.163 (0.140) 0.418 (<0.001)
Insulin 0.073 (0.509) 0.411 (<0.001)
HOMA-IR 0.031 (0.781) 0.406 (<0.001)
HDL cholesterol -0.015 (0.895) -0.394 (<0.001)
Triglycerides 0.077 (0.485) 0.233 (0.033)
CRP -0.225 (0.038) 0.418 (<0.001)
25OHD -0.103 (0.349) -0.130 (0.240)
All Spearman correlations. Abbreviations: HOMA-IR; Homeostatic Model Assessment of Insulin Resistance, HDL; high-density lipoprotein, 
CRP; C-reactive protein, 25OHD; 25-hydroxyvitamin D.
Figure 2. Comparisons of calf muscle density, visceral fat area, fasting glucose and C-reactive protein levels between groups stratified 
by low (≤9) or normal (>9) SPPB scores. #Mann-Whitney test for difference between groups, others are independent samples t-tests.
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during ageing but these independent associations, if 
supported by longitudinal data, suggest it should be a focus 
for interventions targeting physical function in overweight 
and obese older adults.
It seems logical that accumulation of fat in one ectopic 
compartment might indicate similar increases in other ectopic 
compartments, and that appears to be supported by the 
fact that calf muscle density was negatively correlated with 
visceral fat area in this study. However, the correlation with 
visceral fat area was low in magnitude and a previous study 
using magnetic resonance imaging demonstrated positive 
sex-adjusted associations for erector spinae IMAT with intra-
abdominal adipose tissue (β=0.6; P<0.01) in adults aged ≤50 
years, but not older adults (P>0.05)28. These findings suggest 
that higher IMAT is representative of abdominal adiposity 
in younger adults, with both potentially reflecting higher 
sedentary behaviour or poor diets. However, distribution of 
body fat notably shifts from subcutaneous to ectopic depots 
from middle-age and beyond29, indicating age-related factors, 
such as hormonal changes and comorbidities, primarily 
contribute to accumulation of visceral fat in older adults.
The results from this study suggest that visceral adipose 
tissue and calf muscle density have differing associations 
with biochemical cardiometabolic health and inflammatory 
markers. Only visceral fat area, not calf muscle density, 
was associated with CRP and fasting glucose after mutual 
adjustment, and visceral fat area was also significantly 
correlated with fasting glucose, insulin, HOMA-IR, HDL 
cholesterol and triglycerides. Higher IMAT levels have 
been associated with increased insulin resistance30 and 
inflammatory markers31 in studies not adjusting for visceral 
adipose tissue. However, similar to the current study, 
Guglielmi et al. reported that serum triglycerides levels 
were not significantly associated with IMAT after adjustment 
for abdominal adiposity28, suggesting that relationships of 
IMAT with markers of poor cardiometabolic health are not 
independent of other ectopic fat compartments. Furthermore, 
an analysis of almost 3,000 participants of the Health ABC 
Study demonstrated that intermuscular fat was positively 
associated with insulin levels in normal weight, but not 
obese, older adults32. It is possible that high levels of visceral 
adiposity commonly observed in obese individuals make a 
Table 3. Correlation coefficients (P-values) for features of insulin resistance with physical function parameters.
Calf muscle density Visceral fat area Fasting glucose* HOMA-IR* CRP*
Hand grip strength 0.085 (0.438) 0.166 (0.130) -0.004 (0.969) 0.094 (0.396) -0.141 (0.200)
Knee extension 
strength 
0.197 (0.070) -0.143 (0.192) -0.194 (0.078) -0.063 (0.569) -0.164 (0.132)
Path length -0.353 (0.001) 0.072 (0.527) 0.165 (0.149) 0.090 (0.434) 0.281 (0.012)
Stair climb time -0.434 (<0.001) 0.207 (0.057) 0.162 (0.142) 0.105 (0.344) 0.238 (0.028)
Chair stands time -0.370 (0.001) 0.034 (0.763) 0.202 (0.070) 0.028 (0.802) 0.034 (0.762)
Gait speed 0.170 (0.123) -0.160 (0.147) -0.151 (0.175) -0.126 (0.258) -0.078 (0.479)
SPPB score 0.322 (0.003) -0.220 (0.043) -0.293 (0.007) -0.140 (0.207) -0.008 (0.941)
M-FES score 0.401 (<0.001) -0.169 (0.122) -0.112 (0.314) -0.050 (0.655) 0.053 (0.629)
Pearson correlations except *Spearman correlations.
Table 4. Multivariable linear regression analyses exploring associations between muscle density and physical function with adjustment for 
features of insulin resistance.
Model 1 Model 2 Model 3
Hand grip strength (kg) 0.043 (-0.359, 0.444) -0.034 (-0.484, 0.415) -0.015 (-0.469, 0.440)
Knee extension strength (kg) 0.395 (-0.121, 0.912) 0.130 (-0.440, 0.699) 0.112 (-0.465, 0.689)
Path length (cm) -1.780 (-2.696, -0.865) -1.638 (-2.687, -0.589) -1.573 (-2.630, -0.515)
Stair climb time (s) -0.267 (-0.405, -0.129) -0.235 (-0.393, -0.077) -0.219 (-0.376, -0.061)
Chair stands time (s) -0.797 (-1.405, -0.188) -0.886 (-1.556, -0.216) -0.866 (-1.553, -0.179)
Gait speed (m/s) 0.005 (-0.005, 0.014) 0.003 (-0.008, 0.014) 0.003 (-0.008, 0.014)
SPPB score 0.144 (0.043, 0.244) 0.113 (0.004, 0.222) 0.118 (0.007, 0.228)
M-FES score 2.263 (1.293, 3.234) 2.302 (1.230, 3.374) 2.346 (1.261, 3.431)
Data are regression coefficients and (95% CI) for muscle density (mg/cm3). Model 1 adjusted for age, sex and moderate/vigorous physical 
activity. Model 2 adjusted for Model 1 plus fasting glucose and visceral adipose tissue. Model 3 adjusted for Model 2 plus CRP. Abbreviations: 
SPPB; Short Physical Performance Battery, M-FES; Modified Falls Efficacy Scale.
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greater contribution to insulin resistance than the smaller 
IMAT compartment, which may explain why muscle density 
was not associated with cardiometabolic parameters in the 
overweight and obese cohort examined in the present study.
Despite the fact that lower levels of calf muscle density were 
not associated with cardiometabolic or inflammation markers 
in multivariable models, it was a consistent independent 
predictor of poor physical function in this population of 
overweight and obese community-dwelling older adults. 
Research has demonstrated that characteristics of obesity 
and T2DM such as abdominal adiposity, insulin resistance and 
high inflammatory markers are associated with accelerated 
functional decline in older adults9. In the InCHIANTI study, 
participants with T2DM demonstrated slow walking speed 
and 10-15% of the difference compared with non-diabetic 
participants was explained by their lower calf muscle density33. 
The present study similarly suggests that lower levels of calf 
muscle density make an important independent contribution 
to poor physical function in overweight and obese older 
adults. In fully adjusted models, higher calf muscle density 
was associated with better mobility and balance, consistent 
with our previous research14. These associations likely 
explain the relationship of higher muscle density with greater 
self-reported falls efficacy, and high calf muscle density has 
been associated with reduced likelihood of falls in women34. 
Improvements in muscle density may therefore increase 
obese older adults’ confidence in their ability to avoid falls 
during daily activities, which is an important outcome for this 
population who have increased falls risk6 and who are likely to 
benefit from increased activity levels.
Our mediation analyses confirmed that characteristics 
of T2DM did not mediate associations of lower muscle 
density with poor physical function, suggesting that other 
mechanisms explain the effect of IMAT on muscle function. 
A direct effect of higher IMAT content in muscle may be a 
reduction in contractile tissue area as well as deleterious 
alterations in muscle fibre orientation and force 
capacity35. It has been suggested that IMAT impairs blood 
flow to muscle13, and this may also have negative effects 
on muscle function. Furthermore, higher intramuscular 
fat is linked with mitochondrial dysfunction which may 
be related to increased risk for T2DM36, but also declines 
in physical function37. However, it should also be noted 
that the measurement of CRP as an inflammatory marker 
in this study may not reflect the associations of muscle 
density with inflammatory markers such as interleukin-6 
and tumour necrosis factor-α which may mediate its 
relationship with physical function31.
The primary limitations of this study were its cross-
sectional design and relatively small sample size which was 
recruited via convenience sampling and not based on power 
calculations. There were also no adjustments made for the 
multiple comparisons performed in our analyses. The cohort 
consisted of older overweight and obese community-dwelling 
adults, and the results may not be generalisable to those of 
very old age or with extreme obesity. Indeed, no participant 
in this study met criteria for sarcopenia, although this was 
explained by the absence of participants with low muscle 
mass rather than poor physical function. Furthermore, 
mean calf muscle density in our cohort was slightly higher 
than that reported in the InCHIANTI study (72 vs 70 mg/
cm3)33, likely owing to the younger mean age of our cohort 
(63 vs 74 years). A CT assessment of visceral adipose tissue 
may have improved comparability with the calf muscle 
density assessment, although DXA-assessed visceral fat 
area shows excellent agreement with CT assessments17 
and its independent relationships with biochemical markers 
of cardiometabolic health provide confidence in the DXA 
measure in this study. However, CRP, fasting glucose and 
HOMA-IR are not gold-standard assessments of inflammation 
and insulin resistance status and future studies should 
explore measurements including local proinflammatory 
cytokines and hyperinsulinaemic-euglycaemic clamps.
Nevertheless, the findings of the present study suggest 
that improvements in features of insulin resistance may 
not necessarily be beneficial in reducing the effects of 
lower levels of calf muscle density on physical function in 
overweight and obese older adults. As such, interventions 
should specifically target improvements in muscle density. 
A trial of dietary restriction and exercise versus a health 
education control for six months in twenty-seven obese 
middle aged and older women demonstrated that this 
intervention reduced both thigh and calf IMAT, but only 
reductions in calf IMAT were associated with an increase 
in walking speed38. Another study demonstrated that six 
months of dietary restriction and exercise in obese older 
adults resulted in greater declines in thigh IMAT than 
exercise and health education, suggesting weight loss is 
key for reducing IMAT in this population39. In addition, in 
mobility-limited older adults with low vitamin D status, 
six months of exercise plus a nutritional supplement 
containing protein and vitamin D, improved thigh muscle 
composition better than exercise alone40. Thus, weight loss 
(while maintaining adequate nutritional intake), combined 
with exercise, appears the best strategy for improving 
lower-limb muscle density with subsequent functional 
benefits in obese older adults.
In conclusion, higher calf muscle density predicts better 
physical function in overweight and obese older adults. This 
effect is independent and does not appear to be explained 
by lower levels of insulin resistance, visceral adiposity or 
inflammation, suggesting interventions aimed at improving 
physical function in obesity should specifically target 
increasing muscle density.
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